CINECA IRIS Institutional Research Information System

BASOLO, FULVIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 34.043
AS - Asia 16.884
EU - Europa 14.184
SA - Sud America 2.661
AF - Africa 819
OC - Oceania 26
Continente sconosciuto - Info sul continente non disponibili 17
Totale 68.634
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 33.138
SG - Singapore 5.261
CN - Cina 4.543
IT - Italia 4.199
HK - Hong Kong 2.908
SE - Svezia 2.483
BR - Brasile 2.229
DE - Germania 2.215
VN - Vietnam 1.419
BG - Bulgaria 1.105
GB - Regno Unito 937
TR - Turchia 842
CA - Canada 675
FR - Francia 614
FI - Finlandia 573
RU - Federazione Russa 535
AT - Austria 449
UA - Ucraina 396
IN - India 377
CI - Costa d'Avorio 323
KR - Corea 315
JP - Giappone 295
BD - Bangladesh 172
SN - Senegal 151
NL - Olanda 143
CH - Svizzera 137
AR - Argentina 135
IQ - Iraq 132
PK - Pakistan 90
BE - Belgio 88
MX - Messico 87
ID - Indonesia 77
SA - Arabia Saudita 77
ZA - Sudafrica 68
PL - Polonia 65
VE - Venezuela 65
MA - Marocco 64
EC - Ecuador 63
UZ - Uzbekistan 55
CO - Colombia 53
ES - Italia 48
NG - Nigeria 47
JO - Giordania 40
KE - Kenya 29
EG - Egitto 28
PY - Paraguay 28
MY - Malesia 27
CL - Cile 25
IL - Israele 25
LT - Lituania 25
UY - Uruguay 24
AU - Australia 23
IR - Iran 23
JM - Giamaica 23
TN - Tunisia 23
PA - Panama 21
PE - Perù 21
AZ - Azerbaigian 20
NP - Nepal 20
PH - Filippine 20
IE - Irlanda 19
RO - Romania 19
CZ - Repubblica Ceca 17
DZ - Algeria 17
AL - Albania 16
BJ - Benin 16
CR - Costa Rica 15
DO - Repubblica Dominicana 15
GR - Grecia 15
HU - Ungheria 15
OM - Oman 15
TT - Trinidad e Tobago 15
ET - Etiopia 14
EU - Europa 14
AE - Emirati Arabi Uniti 13
BO - Bolivia 13
PT - Portogallo 13
KZ - Kazakistan 12
LB - Libano 12
PS - Palestinian Territory 12
HN - Honduras 11
RS - Serbia 11
TW - Taiwan 11
BY - Bielorussia 8
EE - Estonia 8
KG - Kirghizistan 8
BH - Bahrain 7
BN - Brunei Darussalam 7
NI - Nicaragua 7
GA - Gabon 6
AM - Armenia 5
AO - Angola 5
BB - Barbados 5
DK - Danimarca 5
GT - Guatemala 5
LK - Sri Lanka 5
QA - Qatar 5
SY - Repubblica araba siriana 5
BS - Bahamas 4
BZ - Belize 4
Totale 68.522
Salva come PNG Salva come JPEG
Città #
Ashburn 3.688
Fairfield 3.026
Singapore 2.880
Hong Kong 2.767
Woodbridge 2.475
Dallas 2.188
Chandler 2.170
Houston 1.813
San Jose 1.693
Ann Arbor 1.627
Santa Clara 1.625
Seattle 1.281
Wilmington 1.118
Sofia 1.097
Cambridge 1.007
Shanghai 1.002
Beijing 981
New York 799
Milan 694
Boardman 529
Ottawa 524
Izmir 511
Serra 504
Princeton 485
Los Angeles 443
Lawrence 442
Jacksonville 438
Lauterbourg 398
Medford 393
Vienna 392
Hefei 375
Ho Chi Minh City 355
Abidjan 322
Nanjing 318
Seoul 297
Des Moines 258
Tokyo 256
Florence 253
Council Bluffs 244
Hanoi 244
Pisa 243
Munich 227
London 222
Istanbul 210
Frankfurt am Main 202
San Diego 200
São Paulo 191
Dearborn 189
Columbus 181
Buffalo 180
The Dalles 175
Redondo Beach 162
Rome 161
Dakar 151
Dong Ket 147
Helsinki 127
Nanchang 120
Bern 115
Bremen 112
Boulder 93
Falls Church 91
Kunming 90
Ogden 90
Chicago 83
Brussels 81
Orem 81
Turku 79
Rio de Janeiro 74
Lancaster 69
Shenyang 69
Jüchen 68
Naples 68
Changsha 67
Redwood City 63
Belo Horizonte 57
Hebei 54
Pune 53
Washington 53
Baghdad 52
Düsseldorf 51
Tashkent 51
Da Nang 48
Bologna 47
Fuzhou 47
Guangzhou 47
Norwalk 46
Nürnberg 46
Tianjin 46
Toronto 46
Warsaw 43
Cascina 42
Jiaxing 42
Phoenix 42
Amsterdam 41
Lagos 41
Nuremberg 41
San Francisco 41
Brasília 40
Montreal 40
Hangzhou 39
Totale 47.589
Salva come PNG Salva come JPEG
Nome #
I CARCINOMI PAPILLARI E MIDOLLARI DELLA TIROIDE PRESENTI CONTEMPORANEAMENTE HANNO ORIGINE GENETICA INDIPENDENTE 1.151
L’ANALISI GENETICA DI CARCINOMI PAPILLARI E MIDOLLARI DELLA TIROIDE PRESENTI CONTEMPORANEAMENTE RIVELA LA LORO NATURA CASUALE 340
LOW PREVALENCE OF THE SOMATIC M918T RET MUTATION IN MICRO-MEDULLARY THYROID CANCER. 273
Antiproliferative and Proapoptotic Activity of Sunitinib on Endothelial and Anaplastic Thyroid Cancer Cells via Inhibition of Akt and ERK1/2 Phosphorylation and by Down-Regulation of Cyclin-D1. 267
Prognostic significance of somatic RET oncogene mutations in sporadic medullary thyroid cancer: A 10 years follow up study 262
null 259
ALL-TRANS RETINOIC ACID TREATMENT INHIBITS THE GROWTH OF RARb mRNA EXPRESSING THYROID CANCER CELL LINES BUT DOES NOT RE-INDUCE THE EXPRESSION OF THYROID SPECIFIC GENES 256
Are the clinical and pathological features of differentiated thyroid carcinoma really changed over the last 35 years? Study on 4187 patients from a single Italian institution to answer this question. 253
Anaplastic thyroid carcinoma: from clinicopathology to genetics and advanced therapies 251
Low-Risk Differentiated Thyroid Cancer with BRAFV600E mutation is more difficult to cure than negative cases: a 5-year follow-up study. 249
Identification of two distinct molecular subtypes by digital RNA counting of "non-invasive follicular tumour with papillary-like nuclear features (NIFTP)" 248
EGFR ligands as pharmacodynamic biomarkers in metastatic colorectal cancer patients treated with cetuximab and irinotecan 242
Presence in the pre-surgical fine-needle aspiration of potential thyroid biomarkers previously identified in the post-surgical one. 240
Somatostatin analogues do not affect calcium metabolism in patients with acromegaly and primary hyperparathyroidism due to MEN 1-Like syndrome 239
Changing Trend of Thyroglobulin Antibodies in Patients with Differentiated Thyroid Cancer Treated with Total Thyroidectomy Without ¹³¹I Ablation 239
The presence of a tall cells>10% in a classical variant of papillary thyroid carcinoma (CV-PTC) makes its aggressiveness similar to that of tall cell variant (TCV-PTC) 231
Active surveillance in papillary thyroid microcarcinomas is feasible and safe: experience at one single Italian center 228
Chromosome 10 and RET gene copy number alterations in hereditary and sporadic Medullary Thyroid Carcinoma 227
Ret Genetic Screening in Patients with Medullary Thyroid Cancer and Their Relatives: Experience with 807 Individuals at One Center 226
Developing a tool that could reliably refute total thyroidectomy for solitary Bethesda IV thyroid nodules 225
Identification of a novel point mutation in the RET gene (Ala883Thr), which is associated with medullary thyroid carcinoma phenotype only in homozygous condition 222
Molecular testing in the diagnosis of differentiated thyroid carcinomas 222
Expression and mutational status of c-kit in small-cell lung cancer: prognostic relevance 221
A complex MEN2 syndrome, a mixture of 2B and 2A, associated with a new RET germiline deletion. 221
Incidental versus clinically evident thyroid cancer: A 5-year follow-up study 220
A proteomic profile of washing fluid from the colorectal tract to search for potential biomarkers of colon cancer. 218
Picornavirus-induced immuno-suppression 216
Is elastography actually useful in the presurgical selection of thyroid nodules with indeterminate cytology? 216
Classical point mutations of RET, BRAF and RAS oncogenes are not shared in papillary and medullary thyroid cancer occurring simultaneously in the same gland 216
First evidence of TRPV5 and TRPV6 channels in human parathyroid glands: possible involvement in neoplastic transformation. 214
Evaluation of telomerase in the development and progression of colon cancer. Int J Mol Med. 2002 Nov;10(5):589-92 213
Prophylactic central compartment lymph node dissection in papillary thyroid carcinoma: Clinical implications derived from the first prospective randomized controlled single institution study 213
RET genetic screening of sporadic medullary thyroid cancer (MTC) allows the preclinical diagnosis of unsuspected gene carriers and the identification of a relevant percentage of hidden familial MTC (FMTC) 212
Delayed 131-I First Treatment After Surgery has No Impact on the Median Term Outcome of Patients with Intermediate Risk Differentiated Thyroid Cancer 211
A pandemic recap: lessons we have learned 208
Metastasis of renal cell carcinoma to the parathyroid gland 16 years after radical nephrectomy: A case report 206
mRNA and miRNA expression profiling of follicular variant of papillary thyroid carcinoma with and without distant metastases 206
A proteomic approach to study parathyroid glands 203
BRAF(V600E) mutation and outcome of patients with papillary thyroid carcinoma: A 15-year median follow-up study 203
Evaluation of formalin-fixed paraffin-embedded tissues in the proteomic analysis of parathyroid glands. 202
A ganglioneuroma with features of a thyroid nodule: intense pain on fine needle biopsy as a diagnostic clue 202
Real-Time Elastosonography: Useful Tool for Refining the Presurgical Diagnosis in Thyroid Nodules with Indeterminate or Nondiagnostic Cytology 201
The Molecular Signature More Than the Site of Localization Defines the Origin of the Malignancy 196
Surgical treatment of pleural recurrence from thymoma 194
Cytological and Ultrasound Features of Thyroid Nodules Correlate with Histotypes and Variants of Thyroid Carcinoma 193
PRODUCTIVE HIV-1 INFECTION OF NORMAL HUMAN MAMMARY EPITHELIAL-CELLS 193
Chromosome 10 and RET gene copy number alterations in hereditary and sporadic Medullary Thyroid Carcinoma. 193
Indeterminate Single Thyroid Nodule: Synergistic Impact of Mutational Markers and Sonographic Features in Triaging Patients to Appropriate Surgery. 192
Advanced stage thymomas and thymic carcinomas: results of multimodality treatments 191
Invasive phenotype of MCF10A cells overexpressing c-Ha-ras and c-erbB-2 oncogenes 190
A high vascular count and overexpression of Vascular Endothelial Growth Factor (VEGF) are associated with unfavorable prognosis in operated Small Cell Carcinoma (SCLC) 190
Prevalence of papillary thyroid cancer (PTC) in patients affected by medullary thyroid cancer (MTC) 189
miR-19a and miR-20a and tissue factor expression in activated human peripheral blood mononuclear cells 189
FR-MLV INFECTION INDUCES ERYTHROLEUKEMIA INSTEAD OF LYMPHOID LEUKEMIA IN MICE GIVEN PITUITARY GRAFTS 188
Acute pressure overload induces oxidative stress and tPA expression in rat mesenteric small arteries 188
KRAS and BRAF mutational analyses in a phase II trial of first-line FOLFOXIRI plus bevacizumab (BV) in metastatic colorectal cancer (mCRC) patients (pts) 188
Mutations of Fas (APO-1/CD95) and p53 genes in nonmelanoma skin cancer 188
DIABETES MELLITUS 187
MULTIPLE ORGAN-REACTIVITY OF MONOCLONAL AUTOANTIBODIES TO MOUSE ERYTHROCYTES 187
Pre- And Post-Operative Circulating Tumoral Dna In Patients With Medullary Thyroid Carcinoma 187
The Italian Consensus for the Classification and Reporting of Thyroid Cytology: Cytohistologic and molecular correlations on 37,371 nodules from a single institution 187
Simian virus 40-like sequences from early and late regions in human thyroid tumors of different histotypes 186
The large majority of 1520 patients with indeterminate thyroid nodule at cytology have a favorable outcome, and a clinical risk score has a high negative predictive value for a more cumbersome cancer disease. 186
Role Of Prophylactic Central Compartment Lymph Node Dissection On The Outcome Of Patients With Papillary Thyroid Carcinoma And Synchronous Ipsilateral Cervical Lymph Node Metastases 186
Adipose tissue in COVID-19: detection of SARS-CoV-2 in adipocytes and activation of the interferon-alpha response 186
BRAFV600E mutation, but not RET/PTC rearrangements, is correlated with a lower expression of both thyroperoxidase and sodium iodide symporter genes in papillary thyroid cancer 184
Angiogenesis in intracranial meningiomas: immunohistochemical and molecular study 183
b-Gamma-glutamyltransferase activity in human vulnerable carotid plaques. 183
SYSTEMIC LYMPHOID ATROPHY IN COXSACKIE-VIRUS B3-INFECTED MICE - EFFECTS OF VIRUS AND IMMUNOPOTENTIATING AGENTS 182
Thyroglobulin autoantibodies in patients with papillary thyroid carcinoma: comparison of different assays and evaluation of causes of discrepancies. 182
Correlation between the BRAF V600E Mutation and Tumor Invasiveness in Papillary Thyroid Carcinomas Smaller than 20 Millimeters: Analysis of 1060 Cases 182
Papillary thyroid cancer: Pathological parameters as prognostic factors in different classes of age 182
BRAF(K601E) Mutation in a Follicular Thyroid Adenoma 182
Clinical, pathological and genetic features of anaplastic and poorly differentiated thyroid cancer: A single institute experience 182
Alterations of Fas (APO-1/CD95) gene and its relationship with p53 in non small cell lung cancer 181
Applications of tissue microarray technology in immunohistochemistry: a study on c-kit expression in small cell lung cancer 181
Intrathyroidal differentiated thyroid carcinoma: Tumor size-based surgical concepts 180
Higher intratumoral expression of CD1a, tryptase, and CD68 in a follicular variant of papillary thyroid carcinoma compared to adenomas: correlation with clinical and pathological parameters 180
Patients with indeterminate thyroid nodules at cytology and cancer at histology have a more favourable outcome with respect to patients with suspicious or malignant cytology 180
Management of peritoneal carcinomatosis with cytoreductive surgery combined with intraperitoneal chemohyperthermia at a novel italian center 179
Outcome of classical (CVPTC) and follicular (FVPTC) variants of papillary thyroid cancer: 15 years of follow-up 178
Potential impact of BMI on the aggressiveness of presentation and clinical outcome of Differentiated Thyroid Cancer 178
Influence of T and N stages on long term survival in resectable small cell lung cancer 177
Neoangiogenesis and p53 protein in lung cancer: Their prognostic role and their relation with vascular endothelial growth factor (VEGF) expression 177
Early treatment of hereditary medullary thyroid carcinoma after attribution of multiple endocrine neoplasia type 2 gene carrier status by screening for ret gene mutations 177
MATRIGEL PROMOTES RETINOBLASTOMA CELL-GROWTH INVITRO AND INVIVO 176
Hashimoto's thyroiditis is associated with papillary thyroid carcinoma: role of TSH and of treatment with L-thyroxine 176
Twenty years of lesson learning: How does the RET genetic screening test impact the clinical management of medullary thyroid cancer? 176
Contralateral papillary thyroid cancer is frequent at completion thyroidectomy with no difference in low- and high-risk patients 175
Effects of esomeprazole on healing of non-steroidal anti-inflammatory drug (NSAID)-induced gastric ulcers in the presence of a continued NSAID treatment: characterization of molecular mechanisms 175
E-selectin expression and BRAF status in papillary thyroid carcinomas: Correlation with clinicopathologic features 175
Association of T and B Cells Infiltrating Orbital Tissues With Clinical Features of Graves Orbitopathy 175
Fifty years after the first description, the MEN 2B syndrome diagnosisis still late: description of two recent cases 175
BRAFV600E mutation: a potential predictor of more than a Sistrunk's procedure in patients with thyroglossal duct cyst carcinoma and a normal thyroid gland 175
Thyroglobulin changes are highly dependent on TSH in low-risk DTC patients not treated with 131I 175
Effect of Interferon-alpha and -beta on NIS, TPO and Thyroglobulin expression in primary human thyroid cell cultures 174
Clinical features of thyroid autoimmunity are associated with thyroiditis on histology and are not predictive of malignancy in 570 patients with indeterminate nodules on cytology who had a thyroidectomy 174
Chromosome 10 and RET gene copy number alterations in hereditary and sporadic Medullary Thyroid Carcinoma. 174
Variable modulation by cytokines and thiazolidinediones of the prototype Th1 chemokine CXCL10 in anaplastic thyroid cancer. 174
GENETIC MARKERS TO DISCRIMINATE BENIGN AND MALIGNANT THYROID NODULES WITH UNDETERMINED CYTOLOGY IN AN AREA OF BORDERLINE IODINE DEFICIENCY. 173
Totale 21.158
Salva come PNG Salva come JPEG
Categoria #
all - tutte 199.143
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 199.143
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021778 0 0 0 0 0 0 0 0 0 0 231 547
2021/20225.354 124 221 151 396 993 829 161 236 281 264 292 1.406
2022/20237.074 888 955 513 640 754 885 99 572 1.192 64 433 79
2023/20244.448 476 416 481 357 634 834 189 155 145 116 174 471
2024/202514.989 123 570 152 900 1.445 1.488 1.210 851 1.579 1.875 1.578 3.218
2025/202615.301 1.077 2.198 2.206 1.391 1.470 1.416 2.427 703 804 1.445 164 0
Totale 69.534